Literature DB >> 953057

[Chemistry of urinary mannosides excreted in mannosidosis].

G Strecker, B Fournet, S Bouquelet, J Montreuil, J L Dhondt, J P Farriaux.   

Abstract

Mannose-rich oligosaccharides have been isolated from urines of 5 patients with mannosidosis. Their compositon and structure were determined. Three of them have been previously described by Norden et al: alpha p-Manp-(1 leads to 3) beta-d-Manp-(1 leads to 4) d-GlcNAcp; alpha-p-Manp-(1 leads to 2), alpha-d-Manp-(1 leads to 3) beta-d-Manp-(1 leads to 4) d-GlcNAc and alpha-d-Manp-(1 leads to 2) alpha-d-Manp-(1 leads to 2) alpha-d-Manp-(1 leads to 3) beta-d-Manp-(1 leads to 4) d-GlcNAcp, but the four others are new entities: alpha-d-Manp-(1 leads to 3) (alpha-d-Manp-(1 leads to 2) alpha-d-Manp-(1 leads to 2) alpha-d-Manp-(1 leads to 6) beta-d-Manp-(1 leads to 4) GlcNAcp; alpha-d-Manp-(1 leads to 2) alpha-d-Manp-(1 leads to 3) (alpha-d-Manp-(1 leads to 2) alpha-d-Manp-(1 leads to 6) beta-d-Manp-(1 leads to 4) GlcNAcp; alpha-d-Manp-(1 leads to 2), alpha-d-Man-(1 leads to 3) (alpha-d-Manp-(1 leads to 6) beta-d-Manp-(1 leads to 4) GlcNAp and alpha-d-Manp-(1 leads to 2) alpha-d-Manp-(1 leads to 3) (alpha-d-Manp-(1 leads to 6) beta-d-Manp-(1 leads to 4) GlcNAcp. These structures are related to the glycans of "oligomannosidic type" present in numerous glycoproteins. All possess a N-acetylglucosamine residue in terminal reducing position and reinforce the hypothesis of Kobata et al. and Montreuil et al. that catabolism of glycans N-glucosidically linked to the protein moiety begins by the aciton of a beta-endo-N-acetylglucosaminidase.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 953057     DOI: 10.1016/s0300-9084(76)80227-1

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  11 in total

1.  Cerebral Magnetic Resonance Spectroscopy Demonstrates Long-Term Effect of Bone Marrow Transplantation in α-Mannosidosis.

Authors:  Else R Danielsen; Allan M Lund; Carsten Thomsen
Journal:  JIMD Rep       Date:  2013-04-24

Review 2.  Urinary oligosaccharides in lysosomal and other metabolic disorders.

Authors:  A Federico; G Guazzi
Journal:  Ital J Neurol Sci       Date:  1982-03

3.  Alpha- and beta-mannosidoses.

Authors:  A Cooper; C E Hatton; M Thornley; I B Sardharwalla
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

4.  Comparative study of the carbohydrate moieties of normal and pathological human immunoglobulins M.

Authors:  A Cahour; P Debeire; L Hartmann; J Montreuil
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

5.  The catabolism of mammalian glycoproteins. Comparison of the storage products in bovine, feline and human mannosidosis.

Authors:  D Abraham; W F Blakemore; R D Jolly; R Sidebotham; B Winchester
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857

6.  Biochemical studies on a case of feline mannosidosis.

Authors:  L J Burditt; K Chotai; S Hirani; P G Nugent; B G Winchester; W F Blakemore
Journal:  Biochem J       Date:  1980-09-01       Impact factor: 3.857

7.  The core-specific lysosomal alpha(1-6)-mannosidase activity depends on aspartamidohydrolase activity.

Authors:  J F Haeuw; T Grard; C Alonso; G Strecker; J C Michalski
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

8.  Urinary oligosaccharide excretion in disorders of glycolipid, glycoprotein and glycogen metabolism. A review of screening for differential diagnosis.

Authors:  A C Sewell
Journal:  Eur J Pediatr       Date:  1980-09       Impact factor: 3.183

9.  Purification and properties of alpha-D-mannosidase from the germinated seeds of Medicago sativa (alfalfa).

Authors:  A Curdel; F Petek
Journal:  Biochem J       Date:  1980-02-01       Impact factor: 3.857

10.  Analysis of urinary oligosaccharides in lysosomal storage disorders by capillary high-performance anion-exchange chromatography-mass spectrometry.

Authors:  Cees Bruggink; Ben J H M Poorthuis; André M Deelder; Manfred Wuhrer
Journal:  Anal Bioanal Chem       Date:  2012-04-20       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.